Patent · US Active

Compounds for use in the treatment of cancer

US8633174B2 · kind B2 · utility

0Cited by

6References

16Claims

0Family size

Assignee

PLEDPHARMA AB · SE

Inventors

Jan-Olof Karlsson · Oslo, NO
Tino Kurz · Säter, SE
Rolf Andersson · Vikingstad, SE

Key dates

Filing date	Feb 16, 2013
Grant date	Jan 21, 2014
Priority date	—
Expiry date	Feb 16, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprise a first compound of Formula I or a physiologically acceptable salt thereof, and a cyto-protective amount of a manganese chelate of N,N′-dipyridoxyl ethylenediamine-N,N′-diacetic acid (MnPLED):wherein R1, R2, R3, R4 and X are defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.